44 related articles for article (PubMed ID: 35543439)
1. A registry-based study of paclitaxel drug-coated balloon angioplasty for the treatment of in-stent restenosis of the femoral-popliteal artery.
Bertges DJ; Eldrup-Jorgensen J; Chaer RA; Stoner MC; Marone LK; Giles KA; DeRubertis BG; Jacobowitz GR; Cronenwett JL;
J Vasc Surg; 2024 May; 79(5):1142-1150.e2. PubMed ID: 38190927
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
Haraguchi T; Kuramitsu S; Tsujimoto M; Kashima Y; Sato K; Fujita T
Catheter Cardiovasc Interv; 2024 Jan; 103(1):97-105. PubMed ID: 37975201
[TBL] [Abstract][Full Text] [Related]
3. Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions.
Toyoshima T; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Higuchi Y; Soga Y;
JACC Cardiovasc Interv; 2024 Mar; 17(5):608-618. PubMed ID: 38479962
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
Ducasse E; Sapoval M; Brunet J; Commeau P; Goueffic Y; Sabatier J; Steinmetz E; Lermusiaux P; Rosset E; Caradu C
J Endovasc Ther; 2024 Apr; ():15266028241248333. PubMed ID: 38659343
[TBL] [Abstract][Full Text] [Related]
5. Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry.
Baumhäkel M; Chkhetia S; Kindermann M
Diagn Interv Radiol; 2018; 24(3):153-157. PubMed ID: 29770768
[TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloon in superficial femoral artery in-stent restenosis.
Gerardi D; Alfani A; Tesorio T; Cioppa A; Esposito G; Stabile E
Postepy Kardiol Interwencyjnej; 2018; 14(1):9-14. PubMed ID: 29743899
[TBL] [Abstract][Full Text] [Related]
7. Drug-Coated Balloon Angioplasty for Carotid Artery In-Stent Restenosis: Case Series.
Eljack A; Shih E; Meidan T; Lanfear A; Taha M; Sayfo S; Gable D; Potluri S
J Endovasc Ther; 2024 Apr; 31(2):305-311. PubMed ID: 36154316
[TBL] [Abstract][Full Text] [Related]
8. Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials.
Sun X; Zhang C; Ma Y; He Y; Zhang X; Wu J
Cardiovasc Diabetol; 2024 Apr; 23(1):132. PubMed ID: 38650038
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Therapy of Femoropopliteal In-Stent Restenosis / Occlusion, 36-month Follow up Study.
Suzuki K; Takahara M; Tobita K; Hayakawa N; Mori S; Iwata Y; Horie K; Nakama T
Vasc Endovascular Surg; 2024 May; ():15385744241253170. PubMed ID: 38739243
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Drug-Coated Balloon in Elderly Patients with Intrastent Restenosis After Lower Extremity Arteriosclerotic Obliterans After Rotarex Thrombus Removal.
Liu D; Liu W
Altern Ther Health Med; 2024 Feb; 30(2):124-132. PubMed ID: 37883753
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "Correlation between fractional flow reserve and imaging findings during drug-coated balloon treatment for femoropopliteal diseases" [Cardiovascular Revascularization Medicine 60 (2024) 66-71].
Iwasaki Y; Shimada T; Sato T; Koike J; Funatsu A; Kobayashi T; Ikeda T; Nakamura S
Cardiovasc Revasc Med; 2024 Jun; ():. PubMed ID: 38871536
[No Abstract] [Full Text] [Related]
12. Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery.
Soga Y; Iida O; Seki SI; Kawasaki D; Anzai H; Ando H; Nakama T; Shinozaki N; Kozuki A; Ishihara M; Urasawa K; Toi S; Tsujita H; Tobita K; Ogata K; Horie K; Hayakawa N; Mori S; Fujihara M; Ohki T; Yuba K; Mano T; Ando K; Nakamura M;
Cardiovasc Intervent Radiol; 2024 Jun; 47(6):730-740. PubMed ID: 38816504
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and femoropopliteal in-stent restenosis.
Voll F; Wolf F; Ingwersen M; Kinstner CM; Kufner S; Ibrahim T; Ott I; Krankenberg H; Fusaro M; Cassese S
Vasa; 2022 Jul; 51(4):247-255. PubMed ID: 35543439
[No Abstract] [Full Text] [Related]
14. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
[TBL] [Abstract][Full Text] [Related]
15. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
Yu C; Tang W; Ren T; Chen Q; Lu R; Gao Y
J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
[TBL] [Abstract][Full Text] [Related]
16. Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.
Cassese S; Ndrepepa G; Kufner S; Byrne RA; Giacoppo D; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
EuroIntervention; 2017 Jul; 13(4):483-489. PubMed ID: 28169215
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-Analysis of Drug-Coated Balloon Angioplasty for In-Stent Restenosis in Femoropopliteal Artery Disease.
Zhen Y; Ren H; Chen J; Chang Z; Wang C; Zheng J
J Vasc Interv Radiol; 2022 Apr; 33(4):368-374.e6. PubMed ID: 34915164
[TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA
JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
